TINOS THERAPEUTICS Trademark

Serial Number: 99622513

TINOS THERAPEUTICS is a trademark filed by Tinos Therapeutics, Inc. on January 29, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 40 - Treatment & Processing

Treatment of materials

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Tinos Therapeutics, Inc. (6 trademarks)

34 Boyce Avenue
Barrington, RI 02806

Entity Type: 03

Legal Representation

Attorney of Record

Nicole Kinsley

365 trademarks filed View all →

Correspondence Address

Nicole Kinsley FOLEY HOAG LLP

155 Seaport Blvd.

Boston, MA 02210

United States

Trademark Details

Filing Date

January 29, 2026

Registration Date

Not Registered

Goods & Services

Custom manufacturing of pharmaceuticals

Pharmaceutical products development; Pharmaceutical research and development

Genetic analysis for medical purposes

pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); pharmaceuticals, namely, viral vector therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)